SpaceOAR Hydrogel is a polyethylene glycol–based hydrogel designed to create space between the prostate and rectum to reduce ...

Tucatinib enhances progression-free survival (PFS) in HER2+ metastatic breast cancer, showcasing promising results in a ...

T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

With the 2025 European Society of Medical Oncology (ESMO) Congress kicking off on Friday, October 17, in Berlin, Germany, Targeted Oncology is bringing you background on the most exciting abstracts ...

The primary end point of the dose-expansion portion was safety of NBTXR3 at the recommended dosage, 1 which was established ...

FDA fast track designation for NG-350A aims to expedite its development for mismatch repair-proficient locally advanced ...

Trials should assess overall survival to evaluate potential harm, with crossover limited to avoid confounding treatment ...

Dr Colette Shen discusses the innovative Study 1100, exploring NBTXR3's safety and efficacy in treating recurrent head and ...

The study reported a higher incidence of serious TEAEs and TEAEs leading to death in the xevinapant group, indicating poor ...

Physician shortages are causing burnout, turnover, and patient access issues, with many considering early retirement or ...

Binod Dhakal, MD, associate professor of medicine in the Division of Hematology at the Medical College of Wisconsin, ...

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...